InvestorsHub Logo
Post# of 14572
Next 10
Followers 971
Posts 382997
Boards Moderated 12
Alias Born 06/24/2011

Re: None

Tuesday, 09/20/2022 8:10:02 AM

Tuesday, September 20, 2022 8:10:02 AM

Post# of 14572
$PVSP Strategic Outlook Summary through Q4 2024: Focus on expanding its Washington State footprint, strengthening its brand repertoire and aggressively expanding its product lineup

We expect in-state revenues generated by all brands and across all product categories to reach $30 million in annualized revenue by end of Q4 2024 with Gross Margins reaching 40% and an adjusted EBIDTA of 30%

Pervasip/Artizen Corp plans to expand its national reach by adding various recreational states to its brand footprint, either via licensing agreements or through acquisitions of recreational cultivation and retail licenses

95% of revenue from Artizen’s brands has come from sales of cannabis flower, supporting its position of the 9th most sold independent flower brand in North America; acquisitions and partnerships will open access to concentrates and edible verticals representing 40% of market sales and heretofore not covered by Artizen products

Artizen projects it will generate $50 million in annualized revenues nationally by end of Q4 2024; this is a conservative estimate that does not include any potential revenue multiples from acquisition of retail opportunities.


24 Months plan detail

Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company

Change the OTC ticker symbol

Re-brand all Pervasip/Artizen assets

Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines

Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business

Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023

Complete the audit and begin the OTC QB application process during Q2 2023

Launch Artizen Wellness Q2 2023

Enter the edibles market in Q2 2023 via acquisition and partnerships

Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024

Close first brand licensing agreement by end of Q4 2022

Close one brand licensing deal every quarter thereafter

Financial Outlook Q3 2022 through Q4 2023

Reach $2.0 million in monthly revenue by end of Q1 2023

Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA

Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA

Reach $50 million in annualized revenue with 35% in adjusted EBIDTA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.